We are live on ! Find out more
DHFB

Dixon Hubard Feinour & Brown Portfolio holdings

AUM $842M
1-Year Est. Return 2.74%
This Fund
S&P 500
This Quarter Est. Return
+3.89%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
AUM
$322M
AUM Growth
+$9.28M
Cap. Flow
+$1.33M
Cap. Flow %
0.41%
Top 10 Hldgs %
24.44%
Holding
184
New
17
Increased
42
Reduced
59
Closed
13

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$6.21M
2
ACN icon
Accenture
ACN
+$5.86M
3
LH icon
Labcorp
LH
+$5.52M
4
EA
Electronic Arts
EA
+$5.12M
5
LRCX icon
Lam Research
LRCX
+$4.42M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$7.03M
2
KR icon
Kroger
KR
+$5M
3
MHK icon
Mohawk Industries
MHK
+$4.88M
4
SLB icon
SLB Ltd
SLB
+$3.51M
5
MPC icon
Marathon Petroleum
MPC
+$3.5M

Sector Composition

Rank Sector Weight
1 Healthcare 25.09%
2 Technology 14.53%
3 Industrials 11.48%
4 Communication Services 9.95%
5 Consumer Discretionary 6.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGEM
151
DELISTED
Ply Gem Holdings, Inc.
PGEM
$234K 0.07%
+17,500
New +$253K
BMO icon
152
Bank of Montreal
BMO
$127B
$229K 0.07%
3,488
DELL icon
153
Dell
DELL
$287B
$226K 0.07%
+16,868
New +$229K
NEA icon
154
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.41B
$225K 0.07%
+15,385
New +$229K
FDX icon
155
FedEx
FDX
$75.1B
$222K 0.07%
+1,270
New +$208K
OKE icon
156
Oneok
OKE
$55.4B
$221K 0.07%
4,300
IFF icon
157
International Flavors & Fragrances
IFF
$21.6B
$220K 0.07%
+1,541
New +$209K
CPRI icon
158
Capri Holdings
CPRI
$1.71B
$218K 0.07%
4,650
-900
-16% -$44.9K
HALO icon
159
Halozyme
HALO
$11.8B
$217K 0.07%
+17,944
New +$183K
CELG
160
DELISTED
Celgene Corp
CELG
$216K 0.07%
2,062
ELV icon
161
Elevance Health
ELV
$85B
$215K 0.07%
1,716
MNP
162
DELISTED
Western Asset Municipal Partners Fund, Inc.
MNP
$214K 0.07%
12,650
-1,700
-12% -$29.7K
SPG icon
163
Simon Property Group
SPG
$72.2B
$212K 0.07%
1,023
CSX icon
164
CSX Corp
CSX
$93.8B
$205K 0.06%
+20,202
New +$191K
NXQ
165
DELISTED
NUVEEN ELECT TAX-FREE INC 2
NXQ
$174K 0.05%
11,933
DTF
166
DTF Tax-Free Income 2028 Term Fund
DTF
$80.7M
$171K 0.05%
10,515
-1,200
-10% -$19.8K
TCRT icon
167
Alaunos Therapeutics
TCRT
$4.88M
$154K 0.05%
183
-33
-15% -$26.5K
PBM
168
DELISTED
PACIFIC BOOKER MINERALS INC.
PBM
$10K ﹤0.01%
+12,000
New +$10K
CVS icon
169
CVS Health
CVS
$122B
-73,425
Closed -$7.03M
DE icon
170
Deere & Co
DE
$168B
-3,230
Closed -$262K
FAST icon
171
Fastenal
FAST
$58.6B
-18,200
Closed -$202K
KR icon
172
Kroger
KR
$34.6B
-135,990
Closed -$5M
LCII icon
173
LCI Industries
LCII
$2.57B
-10,725
Closed -$910K
MHK icon
174
Mohawk Industries
MHK
$9.14B
-25,737
Closed -$4.88M
MPC icon
175
Marathon Petroleum
MPC
$84.6B
-92,313
Closed -$3.5M

Similar funds

Dixon Hubard Feinour & Brown's Q3 2016 Portfolio in Review

As of Q3 2016, Dixon Hubard Feinour & Brown held 184 positions worth $322M, up 3% from $313M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Dixon Hubard Feinour & Brown's Q3 2016 filing shows 17 new, 42 increased, 59 reduced and 13 closed positions. Its largest new stake was Amgen: 36,700 shares worth $6.12M. The largest sale was CVS Health, an estimated $7.03M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.

  • Dixon Hubard Feinour & Brown's largest Q3 2016 buy was Amgen: 36,700 shares worth $6.12M.
  • Dixon Hubard Feinour & Brown added most to Travelers Companies in Q3 2016, an estimated $821K increase.
  • Dixon Hubard Feinour & Brown's biggest Q3 2016 reduction was SLB Ltd, cutting an estimated $3.51M.
  • Dixon Hubard Feinour & Brown fully exited CVS Health in Q3 2016, selling an estimated $7.03M.
  • Dixon Hubard Feinour & Brown's ten largest holdings make up 24% of its $322M portfolio in Q3 2016.
  • Dixon Hubard Feinour & Brown opened 17 new positions and closed 13 in Q3 2016.
  • Dixon Hubard Feinour & Brown's portfolio value rose 3% quarter-over-quarter to $322M.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q3 2016, filed 9 Nov 2016.